Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
124.33
-0.09 (-0.07%)
Oct 13, 2026, 4:00 PM EDT - Market closed
Encompass Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,266 | 10,679 | 9,304 | 6,688 | 5,968 | 6,493 | |
Market Cap Growth | -0.31% | 14.78% | 39.12% | 12.06% | -8.08% | -21.03% |
Enterprise Value | 15,000 | 14,105 | 12,722 | 10,143 | 9,391 | 10,306 |
Last Close Price | 124.33 | 105.36 | 91.09 | 65.45 | 58.12 | 49.64 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.80 | 18.91 | 20.54 | 19.13 | 22.12 | 15.82 |
Forward PE | 19.52 | 18.91 | 20.09 | 18.12 | 18.95 | 14.99 |
PS Ratio | 1.98 | 1.80 | 1.73 | 1.39 | 1.37 | 1.62 |
PB Ratio | 4.73 | 3.26 | 3.27 | 2.91 | 3.21 | 2.71 |
P/TBV Ratio | 12.68 | 13.15 | 19.18 | 76.00 | - | 12.59 |
P/FCF Ratio | 29.67 | 24.32 | 25.82 | 24.98 | 49.04 | 38.17 |
P/OCF Ratio | 10.12 | 9.08 | 9.28 | 7.86 | 8.46 | 9.07 |
PEG Ratio | 1.83 | 1.30 | 1.14 | 1.34 | 1.52 | 0.72 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.42 | 2.38 | 2.37 | 2.11 | 2.16 | 2.57 |
EV/EBITDA Ratio | 10.25 | 10.21 | 10.83 | 10.09 | 10.75 | 11.73 |
EV/EBIT Ratio | 13.43 | 13.39 | 14.54 | 13.86 | 14.90 | 15.63 |
EV/FCF Ratio | 36.28 | 32.12 | 35.31 | 37.89 | 77.16 | 60.59 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.82 | 0.83 | 0.95 | 1.28 | 1.61 | 1.45 |
Debt / EBITDA Ratio | 1.87 | 1.89 | 2.21 | 2.77 | 3.23 | 3.72 |
Debt / FCF Ratio | 6.88 | 6.18 | 7.53 | 10.96 | 24.59 | 20.47 |
Net Debt / Equity Ratio | 0.79 | 0.81 | 0.92 | 1.25 | 1.60 | 1.43 |
Net Debt / EBITDA Ratio | 1.87 | 1.91 | 2.24 | 2.85 | 3.40 | 3.90 |
Net Debt / FCF Ratio | 6.62 | 6.02 | 7.30 | 10.70 | 24.41 | 20.18 |
Asset Turnover | 0.87 | 0.87 | 0.85 | 0.82 | 0.70 | 0.60 |
Quick Ratio | 0.91 | 0.83 | 0.81 | 1.04 | 0.97 | 0.76 |
Current Ratio | 1.19 | 1.08 | 1.06 | 1.28 | 1.25 | 1.23 |
Return on Equity (ROE) | 24.97% | 24.82% | 23.29% | 22.84% | 16.46% | 18.32% |
Return on Assets (ROA) | 9.80% | 9.66% | 8.65% | 7.79% | 6.30% | 6.19% |
Return on Invested Capital (ROIC) | 14.52% | 14.74% | 13.15% | 11.46% | 9.20% | 9.44% |
Return on Capital Employed (ROCE) | 17.00% | 16.80% | 15.40% | 13.40% | 12.50% | 10.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.05% | 5.30% | 4.90% | 5.26% | 4.54% | 6.35% |
FCF Yield | 3.37% | 4.11% | 3.87% | 4.00% | 2.04% | 2.62% |
Dividend Yield | 0.68% | 0.67% | 0.69% | 0.90% | 1.44% | 1.72% |
Payout Ratio | 13.70% | 12.56% | 13.78% | 17.16% | 36.53% | 27.22% |
Buyback Yield / Dilution | 0.98% | -0.60% | -0.89% | -0.90% | -0.20% | -0.40% |
Total Shareholder Return | 1.65% | 0.07% | -0.19% | 0.00% | 1.24% | 1.31% |